CD8A and triple-negative breast carcinoma: Therefore, seven signatures which have been reported for the classification of triple-negative breast cancers (TNBC) immune phenotypes [10], including CD8 T cells, Tfh, Th1, NK, cytolytic activity, inflammation promoting and T-cell co-stimulation, were chosen for further analysis (see Table S1 for all gene sets).